Rodman & Renshaw Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $19

Rodman & Renshaw analyst Michael King has initiated coverage on Agenus (NASDAQ: AGEN) with a Buy rating. The firm has set a price target of $19 for the company's stock.